SU905228A1 - Method for preparing thiourea - Google Patents
Method for preparing thiourea Download PDFInfo
- Publication number
- SU905228A1 SU905228A1 SU802892710A SU2892710A SU905228A1 SU 905228 A1 SU905228 A1 SU 905228A1 SU 802892710 A SU802892710 A SU 802892710A SU 2892710 A SU2892710 A SU 2892710A SU 905228 A1 SU905228 A1 SU 905228A1
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- bis
- synthesis
- derivatives
- trimethylsilyl
- carbonate
- Prior art date
Links
Landscapes
- Polyamides (AREA)
Description
(54) СПОСОБ ПОЛУЧЕНИЯ ПОЛИМОЧЕВИНЫ(54) METHOD FOR OBTAINING POLYMOCHEVINA
II
Изобретение относитс к синтезу высокомолекул рных соединений, а именно к синтезу полимочевины на основе природных диаминокарбоновых кислот, которые могут быть использованы в различных област х медицины в качестве биосовместимых полимеров .The invention relates to the synthesis of high molecular weight compounds, namely the synthesis of polyurea based on natural diaminocarboxylic acids, which can be used in various fields of medicine as biocompatible polymers.
Известен способ получени полимочевины путем взаимодействи диизоцианата с. диаминами в среде диметилформамида t A known method for producing polyurea by reacting a diisocyanate with. diamines in dimethylformamide t
Однако неплавкость и значительна гидрофильность этих продуктов не позвол ет примен ть получаемые полимочевины дл производства пластических масс и волокон.However, the low melting point and the significant hydrophilicity of these products prevent the use of the resulting polyureas for the production of plastics and fibers.
Наиболее близкий к предлагаемому по технической сущности вл етс способ получени полимочевин путем взаимодействи N,N -бистриметилсилильных производных ткиров природных диаминокарбоновых кислот с карбонильными производными орранических соединений в среде апротонного растворител 2.The closest to the proposed technical essence is the method of producing polyureas by reacting N, N -brystrimethylsilyl derivatives of natural diaminocarboxylic acid tkirov with carbonyl derivatives of organic compounds in an aprotic solvent medium 2.
Недостатками известного способа синтеза полимочевины вл ютс ; необходимость применени дл их синтеза диизоцианатов на основе эфиров диаминокарбоновых кислот, которые получают в результате трудоемкого и нетехнологического процесса синтеза, заключающегос в применении абсолютных, легковоспламен ю1Е1Ихс растворителей (например серного эфира), охла дени реакционной среды при фосгенировании N,N -бистриметилснлильных производных зфиров ot-диаминокарбоновых кислот , необходимость многократной высоковакуумной перегонки диизоцианатов с целью доведени их до необходимой кондиции; применение абсолютного спирта (метилового или этилового ) дл деблокировани силилированных аминогрупп; необходимость синтеза большого числа диизоцианатоБ ДЛЯ получени полиночевин различной структурьц например, дл синтеза полимочевин на основе И.ЛИ ДЬ изомеров природной диамино«арбоновой кислоты, необходим синтез ка вдого диизоцианата в отдельности . Цель изобретени - получение по лимочевинь с широким диапазоном свойств при одновременном упрощеНИИ спс:-соба, Указанна цель достигаетс т; . |лто при получении полимочевины ну тем взаимодействи N,N-бистриметшг силильных производных эфиров природных диаминокарбоновых кислот с карбонильными производными органиче ких соединений в среде апротонного ;-:г. ../БОрител в качестве карбонильных производных органических соединений используют бис-(п-нитрофенил )карбонат или бис-(254-динитpoфeнил .)кapбoнaт и реакцию провод т при 20--25С ч и при 80-JOO C . -3 ч ., последующим выделением поли мера-. Иод термином активированный ка |бонат подразумеваетс карбонат стро ОуН-(о) (j-2. 4o))-NO2 - blOi NOi Лслученные таким образом полимоченины имеют Ц 0,3-0,9 дл/г, а по остальным параметрам (ИК-спектрЫ растворимость, температура плавлени идентичны полимерам5 полученным по известному способу из соо.тветствующих диизодианатов, Пример I. В трехгорлой кол бе снабженной мешалкой, вводом и выводом дл аргона, 3,28 г (0,01 мо этилового эфира N,N-бис-триметилсш1Ил- (1)-TMCL-лизина раствор ют в 0 мл M,N диметилацетамида (ДМАА) при добавл ют 3,94 г (0,01 мол бис 254-динитрофенилкарбоната (ДНФК наблюдаетс сильный экзотермический эффект) и включают мешалку. Через ЗГ - 40 мин раствор быстро загустеваiг и образуетс студнеобразна масс лл обеспечени гомогенного течени реакции смесь нагревают до 90 с и пйремешивают 3 ч, все врем продува ; опг.v аргоном. Образуетс в зкий раствору который в гор чем виде вь ливают в воду. Выпавший в виде порошка полимер отфильтровывают. тщатапьно промывают водой; сушат ii экстрагируют в аппарате Сокслепа ацетоне;-), Вы-ход 96% Ifip 0,95 дл/г в диметилсу ьфоксиде , г/дл -fc 25с. Пример 2.В трехгорлой колDEj снабженной мешалкой, вводом и вывoдo s дл аргона, 3, 18 г (0,0 моль) этилового эфира N,N -бис-триметштсшшл-L-лизина раствор ют в Ю мл диметиладетамида, при 25°С добавл ют 3„04 г (OjO мо.чь) бис.: li-нитрофенилкарбоната (наЬлюд&атс экзотер мический эффект) включают мешалку и перемешивают 2 ч,. В зкость раствора при комнатной температуре за этот период времени возрастает незначительно , поэтому включают обогрев и реакционную смесь выдерживают при 6 ч, все врем продува колбу аргоном. Раствор охлаждают до комнатной температуры (образование гелеобразной массы не наблюдалось) и выливают в воду. Полимер (в комплек се с И-нитрофенолом) выпадает в виде жидкой смолы, котора затвердевае по мере отьывки Ь-нитрофг :ла водой Тщательно промьЕтый поли,,. . сушат в вакууме и экстрагируют в аппарате Сокслетта ацетоном Выход полимера 97%, Inp - ДЛ/г в диметилсульфо..е5С 0 „ 5 г/дл, , Пример Зо Синтез полимера осуществл ют в соответствии с методикой , приведенной в примере j с той разницей, что вместо -диметилацетй ,; :ипа и:;:пользутот N-MeTmiлирролидон (N-Mn) о Выход полимера 95%, дл/г в диметилсульфоксиде . Пример 4 Синтез полимера осуществл ют в соответствии с мето дикой приведенной в примере 1, с той разницей, что вместо этилового эфира N,К-бис триметилсилил-1-лизина берут этиловый эфир N,N-бис-триметилсилш1-01-лизина (ДЬ) TMCL. Выход полимера 97% ,76 дл/г в диметилсульфоксиде, ,5 г/дл, t -Пример 5, Синтез полимера осу1цествл5пот в соответствии с примером f с том разницей, что вместо этилового эфира N,N -бис-триметкп силил-1-личина используют этиловый эфир N,М-бис-триметш1силил-1-орнит Выходполимера 90% ,)р 0, 32 дл/г в диметилсульфоксиде, ,5 г/дл, С, Пример 6, Синтез полимера осуществл ют в соответствии с мето дикой, приведенной в примере 1 , с той разницей, что вместо этилового эфира N,N -бис-триметилсилил-L-лиз на используют диэтиловый эфир N,N -бис-триметилсилил-L-цистина. Вы- ход полимера 96%, 0,85 дл/г в диметилсульфоксиде, ,5 г/дл, . Пример 7.В трехгорлую ко бу снабженную мешалкой, вводом и выводом дл аргона помещают 1,59 г (0,005 моль) этилового эфира N,N-бис-метил-С-лизина раствор ют в 10 мл N,N -диметилацетамида, добав л ют 3,94 г (0,01 моль) бис-2,4-динитрофенилкарбоната , включают мешалку и смесь перемешивают при комнатной температуре 2 ч. К реакционному раствору затем добавл ют 2,20 г (0,005 моль) диэтилового эфи ра N,N -бис-триметилсилил-L-цистин ( соотношение производных двух диаминокарбоновых кислот 1:1)включают обогрев и смесь нагревают до 90 С 3 ч. Реакционный раствор выливают в воду. Выпавший полимер отфильтровывают , тщательно промьшают ЕГрдой, сушат и экстрагируют этилаце татом в аппарате Сокслетта. Выход полимера 97%) 0,68 дл/г в диметилсульфоксиде , ,5 г/дл, Пример 8. Синтез полимера осуществл ют в соответствии с методикой , приведенной в примере 7, с той разницей, что вначале вместо этилового эфира N,N -бис-триметилси лил-1-лизина используют диэтиловый эфир N, N -бис-триметилсшпш-Ь-цистина , а затем к регисционному раствору добавл ют этиловый эфир N,N (L) ТМСЛ (ОThe disadvantages of the known polyurea synthesis method are; the need to use for their synthesis diisocyanates based on diaminocarboxylic acid esters, which are obtained as a result of a laborious and nontechnological synthesis process, consisting in the use of absolute, highly flammable J1E1Xx solvents (e.g. - diaminocarboxylic acids, the need for multiple high-vacuum distillation of diisocyanates in order to bring them to the required condition; using absolute alcohol (methyl or ethyl) to release silylated amino groups; the need to synthesize a large number of diisocyanatoB for the preparation of polinocevins of various structures, for example, for the synthesis of polyureas based on I.LI D isomers of the natural diamino arbonic acid, it is necessary to synthesize separately for diisocyanate. The purpose of the invention is to obtain limochevins with a wide range of properties with simultaneous simplification of the THRD: -sob. The specified goal is achieved t; . In the preparation of polyurea, the interaction of N, N-bistrymethyl silyl derivatives of natural diaminocarboxylic acid esters with carbonyl derivatives of organic compounds in an aprotic medium; -: g. ../Britel as a carbonyl derivative of organic compounds, bis- (p-nitrophenyl) carbonate or bis- (254-dinitrophenyl.) Can be used and the reaction is carried out at 20-25 ° C and at 80-JOO C. -3 hours, followed by isolation of the polymer-. Iodine by the term activated carbon is meant to carbonate OUH- (o) (j-2. 4o)) —NO2 — blOi NOi. The polychlocenes thus obtained have C 0.3–0.9 dl / g, and for the rest of the parameters (IR -spectra solubility, melting point is identical to polymers 5 obtained by a known method from the corresponding diisodianates, Example I. In a three-necked collar equipped with a stirrer, inlet and outlet for argon, 3.28 g (0.01 mo N, N-bis ethyl ester -trimethylsl1Il- (1) -TMCL-lysine was dissolved in 0 ml of M, N dimethylacetamide (DMAA) and 3.94 g (0.01 mol of bis 254-dinitrophenylcarbo Ata (DNFK has a strong exothermic effect) and turn on the stirrer. After ZG - 40 minutes, the solution quickly thickens and a jelly-like mass is formed to ensure a homogeneous flow of the reaction, the mixture is heated up to 90 seconds and re-stirred for 3 hours, purging all the way; argon. a viscous solution that is poured in hot form into water. The polymer which is precipitated in the form of a powder is filtered off and washed thoroughly with water; dried ii extracted in a Coxlep acetone apparatus ;-), You yield 96% Ifip 0.95 dl / g in dimethyl oxide, g / dl -fc 25c. Example 2. In a three-necked column, equipped with a stirrer, inlet and outlet s for argon, 3, 18 g (0.0 mol) of N, N-bis-trimethacryl-L-lysine ethyl ester is dissolved in 10 ml of dimethylethamide, at 25 ° C add 3 „04 g (OjO monk) bis .: li-nitrophenyl carbonate (human diet & exothermic effect) turn on the stirrer and stir for 2 hours. The viscosity of the solution at room temperature for this period of time increases slightly, therefore, include heating and the reaction mixture is maintained at 6 h, all the time blowing the flask with argon. The solution is cooled to room temperature (the formation of a gel-like mass was not observed) and poured into water. The polymer (in combination with I-NITROPHENOL) drops out in the form of a liquid resin, which solidifies as L-nitrofg removes: la Water thoroughly poly. . dried in vacuum and extracted in Soxhlett’s apparatus with acetone. Polymer yield 97%, Inp — DL / g in dimethyl sulfo. e 5 C 0 5 g / dl., Example 3 Synthesis of the polymer is carried out in accordance with the procedure given in example j with the difference that instead of dimethyl acetate,; : ipa i:;: user N-MeTmylirrolidone (N-Mn) o Polymer yield 95%, dl / g in dimethyl sulfoxide. Example 4 Synthesis of the polymer is carried out in accordance with the procedure given in Example 1, with the difference that instead of N, K-bis trimethylsilyl-1-lysine ethyl ester, N, N-bis-trimethylsil-1-01-lysine ethyl ester is taken (Db ) TMCL. The polymer yield is 97%, 76 dl / g in dimethyl sulfoxide, 5 g / dl, t-Example 5, Synthesis of a polymer is of an essence 5 sweat in accordance with example f with the difference that instead of ethyl ester N, N-bis-trimethc silyl-1- The substance used is N, M-bis-trimethyl-silyl-1-ornitol 90% yield of ethyl ester,) p 0, 32 dl / g in dimethyl sulfoxide, 5 g / dl, C, Example 6, Synthesis of the polymer is carried out in accordance with the method shown in example 1, with the difference that instead of ethyl ester N, N-bis-trimethylsilyl-L-lys on the use of diethyl ester N, N-bis-trimethylsilyl-L-cystine. Polymer yield 96%, 0.85 dl / g in dimethyl sulfoxide, 5 g / dl,. Example 7. In a three-necked co with a stirrer, inlet and outlet for argon, 1.59 g (0.005 mol) of N, N-bis-methyl-C-lysine ethyl ester is dissolved in 10 ml of N, N-dimethyl acetamide, added 3.94 g (0.01 mol) of bis-2,4-dinitrophenyl carbonate are added, the stirrer is turned on and the mixture is stirred at room temperature for 2 hours. To the reaction solution is then added 2.20 g (0.005 mol) of diethyl ether N, N -bis-trimethylsilyl-L-cystine (the ratio of two diaminocarboxylic acid derivatives is 1: 1) include heating and the mixture is heated to 90 ° C for 3 hours. The reaction solution is poured into water. The precipitated polymer is filtered off, rinsed thoroughly with an Egrda, dried and extracted with ethyl acetate in a Soxhlett apparatus. The polymer yield is 97%) 0.68 dl / g in dimethyl sulfoxide, 5 g / dl, Example 8. The synthesis of the polymer is carried out in accordance with the procedure described in example 7, with the difference that instead of ethyl N, N - Bis-trimethylsilyl-1-lysine is used with N, N-bis-trimethyl-spm-L-cystine diethyl ether, and then N, N (L) TMSL (O) is added to the registration solution.
ДНФКDNFK
(L) ТМСЛ (О(L) TML (O
ПНФКPFC
ДММА 25/0,5 96 0,95 90/3DMMA 25 / 0.5 96 0.95 90/3
97 0,497 0.4
ДМАА- 25/2 100/6 -бис-триметилсш1ил-1-лизина. Выход полимера 98%, 0,71 дл/л в диметилсульфоксиде , ,5 г/дл, t 25C. Пример 9. Синтез полимера осуществл ют в соответствии с методикой , приведенной в примере 7, с той разницей, что вместо 0,005 берут 0,002 моль этилового эфира N,N -бис-триметилсилил-1-лизина , а вместо 0,005 моль берут 0,008 моль диэтилового эфира N,N -бис-триметилсилил-1-цистина . Выход полимера 96% ,70 дл/г в диметилсульфоксиде, ,5 г/дл, . Пример 10. Синтез полимера осуществл ют в соответствии с методикой, приведенной в примере 7, с той разницей, что берут 0,008 моль этилового эфира N,N -бис-тримет1тсилил-1-лизина и 0,002 моль диэтилового эфира-L-цистина. Выход 97%,lfip 0,68 дл/г в диметилсульфоксиде , ,5 г/дл, . Пример П. Синтез полимера осуществл ют в соответствии с методикой, приведенной в примере 7, с той разницей, что вместо этилового эфира N,N -бис-триметилсилил-L-лизина берут этиловый эфир N,N-бис-триметилсилил-Д1-лизина . Выход полимера 95%,К)рр 0,52 дл/г в диметилсульфоксиде, ,5 г/дл, . Пример 12. Синтез полимера осуществл ют в соответствии с методикой , приведенной в примере 7,, с той разницей, что вместо этилового эфира N,N -бис-триметилсилил-L-лизина берут этиловый эфир N,N-биc-тpимeтилcилил-L-opнитинa . Выход полимера 89%, 0,28 дл/г в иметилсульфоксиде, ,5 г/дл, t 25C. Основные характеристики полуенных полимеров приведены в табли- е.DMAA-25/2 100/6 -bis-trimethylsil-1-lysine. The polymer yield is 98%, 0.71 dl / l in dimethyl sulfoxide, 5 g / dl, t 25C. Example 9. Synthesis of the polymer was carried out in accordance with the procedure described in Example 7, with the difference that 0.002 mol of N, N-bis-trimethylsilyl-1-lysine ethyl ester was taken instead of 0.005, and 0.008 mol of diethyl ether was taken instead of 0.005 mol N, N -bis-trimethylsilyl-1-cystine. The polymer yield 96%, 70 DL / g in dimethyl sulfoxide, 5 g / dL,. Example 10. Synthesis of the polymer was carried out in accordance with the procedure described in Example 7, with the difference that 0.008 mol of N, N-bis-trimethyl-1-silyl-1-lysine ethyl ester and 0.002 mol of L-cystine diethyl ether were taken. Yield 97%, lfip 0.68 dl / g in dimethyl sulfoxide, 5 g / dl,. Example P. Synthesis of the polymer is carried out in accordance with the procedure described in example 7, with the difference that instead of ethyl ester of N, N-bis-trimethylsilyl-L-lysine, take ethyl ester of N, N-bis-trimethylsilyl-D1-lysine . The polymer yield is 95%, K) pp 0.52 dl / g in dimethyl sulfoxide, 5 g / dl,. Example 12. Synthesis of the polymer is carried out in accordance with the procedure given in Example 7, with the difference that instead of N, N-bis-trimethylsilyl-L-lysine ethyl ester, N, N-bis-trimethylsilyl-L- ethyl ester is taken opnitine. The polymer yield is 89%, 0.28 dl / g in imethyl sulfoxide, 5 g / dl, t 25C. The main characteristics of semi-polymers are given in table.
(L) -шел (1)(L) -shap (1)
ДНФКDNFK
(Д1) шел (1)(D1) walking (1)
ДНФКDNFK
(L) тасо (1)(L) taso (1)
ДИФКDIFK
(L) ТМСЦ (1)(L) TMSC (1)
ДНФКDNFK
{L) ТМСЛ (0,5) {L) TML (0.5)
( L) ТМСЦ (0,5) (L) TMSC (0.5)
ДНФК(L) ТМСЦ (0,5)DNFK (L) TMSC (0.5)
++
(L) ТМСЛ (0,5)(L) TML (0.5)
Примечание: ТМСО - этиловый эфир N,N -бис-триметилсилил-орнитина; ТМСЛ - этиловый эфир N,N-биc-тpимeтилcилиллизинa; ТМСЦ - диэтиловый эфир N,N -бис-триметилсилилцистина; ДНФК-бис-2,4-динитрофенилкар6онат, ПНФК-бис п-нитрофенилкарбонат; ДМАА - N,N -диметилацетамид; N-MII-N-метилпирролидон. В зкость определена в диметилсульфоксиде при , ,5 г/дл.Note: TMSO is N, N-bis-trimethylsilyl-ornithine ethyl ester; TMHL is ethyl ester of N, N-bis-trimethylsilyl lysine; TMSC - N, N-bis-trimethylsilylcystine diethyl ether; DNFC-bis-2,4-dinitrophenylcaronate, PNFC-bis p-nitrophenylcarbonate; DMAA - N, N-dimethylacetamide; N-MII-N-methylpyrrolidone. Viscosity is determined in dimethyl sulfoxide at, 5 g / dL.
Применение предлагаемого способа получени полимочевины на основе природных днаминокарбоновых кислот обеспечивает по сравнению с известными способами, следующие преимущества: легкость получени нысокомолекул рных гголимочевин на основе при905228The use of the proposed method for the preparation of polyurea based on natural dinocarboxylic acids provides the following advantages compared with the known methods: ease of preparation of high molecular weight glymethyl urea based on 905228
8 Продолжение таблицы8 Continuation of the table
N-МП 25/0,5 95 0,95 90/3NMP 25 / 0.5 95 0.95 90/3
ДМАА 25/0,5 97 0,76 90/3DMAA 25 / 0.5 97 0.76 90/3
ДМАА25/0,5 900,32DMAA25 / 0.5 900.32
90/390/3
ДМАА 25/0,5 96 0,85 90/3DMAA 25 / 0.5 96 0.85 90/3
Д11АА 25/2 D11AA 25/2
970,68 90/3970.68 90/3
25/225/2
9898
0,710.71
ДМААDMAA
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SU802892710A SU905228A1 (en) | 1980-03-06 | 1980-03-06 | Method for preparing thiourea |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SU802892710A SU905228A1 (en) | 1980-03-06 | 1980-03-06 | Method for preparing thiourea |
Publications (1)
Publication Number | Publication Date |
---|---|
SU905228A1 true SU905228A1 (en) | 1982-02-15 |
Family
ID=20882107
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SU802892710A SU905228A1 (en) | 1980-03-06 | 1980-03-06 | Method for preparing thiourea |
Country Status (1)
Country | Link |
---|---|
SU (1) | SU905228A1 (en) |
Cited By (74)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6503538B1 (en) | 2000-08-30 | 2003-01-07 | Cornell Research Foundation, Inc. | Elastomeric functional biodegradable copolyester amides and copolyester urethanes |
US7304122B2 (en) | 2001-08-30 | 2007-12-04 | Cornell Research Foundation, Inc. | Elastomeric functional biodegradable copolyester amides and copolyester urethanes |
US7648727B2 (en) | 2004-08-26 | 2010-01-19 | Advanced Cardiovascular Systems, Inc. | Methods for manufacturing a coated stent-balloon assembly |
US7648725B2 (en) | 2002-12-12 | 2010-01-19 | Advanced Cardiovascular Systems, Inc. | Clamp mandrel fixture and a method of using the same to minimize coating defects |
US7682669B1 (en) | 2001-07-30 | 2010-03-23 | Advanced Cardiovascular Systems, Inc. | Methods for covalently immobilizing anti-thrombogenic material into a coating on a medical device |
US7691401B2 (en) | 2000-09-28 | 2010-04-06 | Advanced Cardiovascular Systems, Inc. | Poly(butylmethacrylate) and rapamycin coated stent |
US7699889B2 (en) | 2004-12-27 | 2010-04-20 | Advanced Cardiovascular Systems, Inc. | Poly(ester amide) block copolymers |
US7713637B2 (en) | 2006-03-03 | 2010-05-11 | Advanced Cardiovascular Systems, Inc. | Coating containing PEGylated hyaluronic acid and a PEGylated non-hyaluronic acid polymer |
US7735449B1 (en) | 2005-07-28 | 2010-06-15 | Advanced Cardiovascular Systems, Inc. | Stent fixture having rounded support structures and method for use thereof |
US7749263B2 (en) | 2004-10-29 | 2010-07-06 | Abbott Cardiovascular Systems Inc. | Poly(ester amide) filler blends for modulation of coating properties |
US7758881B2 (en) | 2004-06-30 | 2010-07-20 | Advanced Cardiovascular Systems, Inc. | Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device |
US7766884B2 (en) | 2004-08-31 | 2010-08-03 | Advanced Cardiovascular Systems, Inc. | Polymers of fluorinated monomers and hydrophilic monomers |
US7772359B2 (en) | 2003-12-19 | 2010-08-10 | Advanced Cardiovascular Systems, Inc. | Biobeneficial polyamide/polyethylene glycol polymers for use with drug eluting stents |
US7776926B1 (en) | 2002-12-11 | 2010-08-17 | Advanced Cardiovascular Systems, Inc. | Biocompatible coating for implantable medical devices |
US7775178B2 (en) | 2006-05-26 | 2010-08-17 | Advanced Cardiovascular Systems, Inc. | Stent coating apparatus and method |
US7785512B1 (en) | 2003-07-31 | 2010-08-31 | Advanced Cardiovascular Systems, Inc. | Method and system of controlled temperature mixing and molding of polymers with active agents for implantable medical devices |
US7785647B2 (en) | 2005-07-25 | 2010-08-31 | Advanced Cardiovascular Systems, Inc. | Methods of providing antioxidants to a drug containing product |
US7794743B2 (en) | 2002-06-21 | 2010-09-14 | Advanced Cardiovascular Systems, Inc. | Polycationic peptide coatings and methods of making the same |
US7795467B1 (en) | 2005-04-26 | 2010-09-14 | Advanced Cardiovascular Systems, Inc. | Bioabsorbable, biobeneficial polyurethanes for use in medical devices |
US7803394B2 (en) | 2002-06-21 | 2010-09-28 | Advanced Cardiovascular Systems, Inc. | Polycationic peptide hydrogel coatings for cardiovascular therapy |
US7803406B2 (en) | 2002-06-21 | 2010-09-28 | Advanced Cardiovascular Systems, Inc. | Polycationic peptide coatings and methods of coating implantable medical devices |
US7807211B2 (en) | 1999-09-03 | 2010-10-05 | Advanced Cardiovascular Systems, Inc. | Thermal treatment of an implantable medical device |
US7807210B1 (en) | 2000-10-31 | 2010-10-05 | Advanced Cardiovascular Systems, Inc. | Hemocompatible polymers on hydrophobic porous polymers |
US7820732B2 (en) | 2004-04-30 | 2010-10-26 | Advanced Cardiovascular Systems, Inc. | Methods for modulating thermal and mechanical properties of coatings on implantable devices |
US7823533B2 (en) | 2005-06-30 | 2010-11-02 | Advanced Cardiovascular Systems, Inc. | Stent fixture and method for reducing coating defects |
US7892592B1 (en) | 2004-11-30 | 2011-02-22 | Advanced Cardiovascular Systems, Inc. | Coating abluminal surfaces of stents and other implantable medical devices |
US7976891B1 (en) | 2005-12-16 | 2011-07-12 | Advanced Cardiovascular Systems, Inc. | Abluminal stent coating apparatus and method of using focused acoustic energy |
US7985441B1 (en) | 2006-05-04 | 2011-07-26 | Yiwen Tang | Purification of polymers for coating applications |
US7985440B2 (en) | 2001-06-27 | 2011-07-26 | Advanced Cardiovascular Systems, Inc. | Method of using a mandrel to coat a stent |
US8007775B2 (en) | 2004-12-30 | 2011-08-30 | Advanced Cardiovascular Systems, Inc. | Polymers containing poly(hydroxyalkanoates) and agents for use with medical articles and methods of fabricating the same |
US8017140B2 (en) | 2004-06-29 | 2011-09-13 | Advanced Cardiovascular System, Inc. | Drug-delivery stent formulations for restenosis and vulnerable plaque |
US8021676B2 (en) | 2005-07-08 | 2011-09-20 | Advanced Cardiovascular Systems, Inc. | Functionalized chemically inert polymers for coatings |
US8029816B2 (en) | 2006-06-09 | 2011-10-04 | Abbott Cardiovascular Systems Inc. | Medical device coated with a coating containing elastin pentapeptide VGVPG |
US8052912B2 (en) | 2003-12-01 | 2011-11-08 | Advanced Cardiovascular Systems, Inc. | Temperature controlled crimping |
US8062350B2 (en) | 2006-06-14 | 2011-11-22 | Abbott Cardiovascular Systems Inc. | RGD peptide attached to bioabsorbable stents |
US8067025B2 (en) | 2006-02-17 | 2011-11-29 | Advanced Cardiovascular Systems, Inc. | Nitric oxide generating medical devices |
US8067023B2 (en) | 2002-06-21 | 2011-11-29 | Advanced Cardiovascular Systems, Inc. | Implantable medical devices incorporating plasma polymerized film layers and charged amino acids |
US8069814B2 (en) | 2006-05-04 | 2011-12-06 | Advanced Cardiovascular Systems, Inc. | Stent support devices |
US8109904B1 (en) | 2007-06-25 | 2012-02-07 | Abbott Cardiovascular Systems Inc. | Drug delivery medical devices |
US8110211B2 (en) | 2004-09-22 | 2012-02-07 | Advanced Cardiovascular Systems, Inc. | Medicated coatings for implantable medical devices including polyacrylates |
US8147769B1 (en) | 2007-05-16 | 2012-04-03 | Abbott Cardiovascular Systems Inc. | Stent and delivery system with reduced chemical degradation |
US8173199B2 (en) | 2002-03-27 | 2012-05-08 | Advanced Cardiovascular Systems, Inc. | 40-O-(2-hydroxy)ethyl-rapamycin coated stent |
US8192752B2 (en) | 2003-11-21 | 2012-06-05 | Advanced Cardiovascular Systems, Inc. | Coatings for implantable devices including biologically erodable polyesters and methods for fabricating the same |
US8293890B2 (en) | 2004-04-30 | 2012-10-23 | Advanced Cardiovascular Systems, Inc. | Hyaluronic acid based copolymers |
US8304012B2 (en) | 2006-05-04 | 2012-11-06 | Advanced Cardiovascular Systems, Inc. | Method for drying a stent |
US8303651B1 (en) | 2001-09-07 | 2012-11-06 | Advanced Cardiovascular Systems, Inc. | Polymeric coating for reducing the rate of release of a therapeutic substance from a stent |
US8357391B2 (en) | 2004-07-30 | 2013-01-22 | Advanced Cardiovascular Systems, Inc. | Coatings for implantable devices comprising poly (hydroxy-alkanoates) and diacid linkages |
US8435550B2 (en) | 2002-12-16 | 2013-05-07 | Abbot Cardiovascular Systems Inc. | Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device |
US8506617B1 (en) | 2002-06-21 | 2013-08-13 | Advanced Cardiovascular Systems, Inc. | Micronized peptide coated stent |
US8568764B2 (en) | 2006-05-31 | 2013-10-29 | Advanced Cardiovascular Systems, Inc. | Methods of forming coating layers for medical devices utilizing flash vaporization |
US8586069B2 (en) | 2002-12-16 | 2013-11-19 | Abbott Cardiovascular Systems Inc. | Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders |
US8597673B2 (en) | 2006-12-13 | 2013-12-03 | Advanced Cardiovascular Systems, Inc. | Coating of fast absorption or dissolution |
US8603634B2 (en) | 2004-10-27 | 2013-12-10 | Abbott Cardiovascular Systems Inc. | End-capped poly(ester amide) copolymers |
US8609123B2 (en) | 2004-11-29 | 2013-12-17 | Advanced Cardiovascular Systems, Inc. | Derivatized poly(ester amide) as a biobeneficial coating |
US8647655B2 (en) | 2002-12-11 | 2014-02-11 | Abbott Cardiovascular Systems Inc. | Biocompatible polyacrylate compositions for medical applications |
US8652504B2 (en) | 2005-09-22 | 2014-02-18 | Medivas, Llc | Solid polymer delivery compositions and methods for use thereof |
US8673334B2 (en) | 2003-05-08 | 2014-03-18 | Abbott Cardiovascular Systems Inc. | Stent coatings comprising hydrophilic additives |
US8685431B2 (en) | 2004-03-16 | 2014-04-01 | Advanced Cardiovascular Systems, Inc. | Biologically absorbable coatings for implantable devices based on copolymers having ester bonds and methods for fabricating the same |
US8703169B1 (en) | 2006-08-15 | 2014-04-22 | Abbott Cardiovascular Systems Inc. | Implantable device having a coating comprising carrageenan and a biostable polymer |
US8703167B2 (en) | 2006-06-05 | 2014-04-22 | Advanced Cardiovascular Systems, Inc. | Coatings for implantable medical devices for controlled release of a hydrophilic drug and a hydrophobic drug |
US8741378B1 (en) | 2001-06-27 | 2014-06-03 | Advanced Cardiovascular Systems, Inc. | Methods of coating an implantable device |
US8778014B1 (en) | 2004-03-31 | 2014-07-15 | Advanced Cardiovascular Systems, Inc. | Coatings for preventing balloon damage to polymer coated stents |
US8778375B2 (en) | 2005-04-29 | 2014-07-15 | Advanced Cardiovascular Systems, Inc. | Amorphous poly(D,L-lactide) coating |
US9028859B2 (en) | 2006-07-07 | 2015-05-12 | Advanced Cardiovascular Systems, Inc. | Phase-separated block copolymer coatings for implantable medical devices |
US9056155B1 (en) | 2007-05-29 | 2015-06-16 | Abbott Cardiovascular Systems Inc. | Coatings having an elastic primer layer |
US9102830B2 (en) | 2005-09-22 | 2015-08-11 | Medivas, Llc | Bis-(α-amino)-diol-diester-containing poly (ester amide) and poly (ester urethane) compositions and methods of use |
US9114198B2 (en) | 2003-11-19 | 2015-08-25 | Advanced Cardiovascular Systems, Inc. | Biologically beneficial coatings for implantable devices containing fluorinated polymers and methods for fabricating the same |
US9339592B2 (en) | 2004-12-22 | 2016-05-17 | Abbott Cardiovascular Systems Inc. | Polymers of fluorinated monomers and hydrocarbon monomers |
US9364498B2 (en) | 2004-06-18 | 2016-06-14 | Abbott Cardiovascular Systems Inc. | Heparin prodrugs and drug delivery stents formed therefrom |
US9517203B2 (en) | 2000-08-30 | 2016-12-13 | Mediv As, Llc | Polymer particle delivery compositions and methods of use |
US9561309B2 (en) | 2004-05-27 | 2017-02-07 | Advanced Cardiovascular Systems, Inc. | Antifouling heparin coatings |
US9561351B2 (en) | 2006-05-31 | 2017-02-07 | Advanced Cardiovascular Systems, Inc. | Drug delivery spiral coil construct |
US9580558B2 (en) | 2004-07-30 | 2017-02-28 | Abbott Cardiovascular Systems Inc. | Polymers containing siloxane monomers |
US10076591B2 (en) | 2010-03-31 | 2018-09-18 | Abbott Cardiovascular Systems Inc. | Absorbable coating for implantable device |
-
1980
- 1980-03-06 SU SU802892710A patent/SU905228A1/en active
Cited By (94)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7807211B2 (en) | 1999-09-03 | 2010-10-05 | Advanced Cardiovascular Systems, Inc. | Thermal treatment of an implantable medical device |
US6503538B1 (en) | 2000-08-30 | 2003-01-07 | Cornell Research Foundation, Inc. | Elastomeric functional biodegradable copolyester amides and copolyester urethanes |
US7408018B2 (en) | 2000-08-30 | 2008-08-05 | Cornell Research Foundation, Inc. | Elastomeric functional biodegradable copolyester amides and copolyester urethanes |
US9517203B2 (en) | 2000-08-30 | 2016-12-13 | Mediv As, Llc | Polymer particle delivery compositions and methods of use |
US7691401B2 (en) | 2000-09-28 | 2010-04-06 | Advanced Cardiovascular Systems, Inc. | Poly(butylmethacrylate) and rapamycin coated stent |
US7807210B1 (en) | 2000-10-31 | 2010-10-05 | Advanced Cardiovascular Systems, Inc. | Hemocompatible polymers on hydrophobic porous polymers |
US10064982B2 (en) | 2001-06-27 | 2018-09-04 | Abbott Cardiovascular Systems Inc. | PDLLA stent coating |
US7985440B2 (en) | 2001-06-27 | 2011-07-26 | Advanced Cardiovascular Systems, Inc. | Method of using a mandrel to coat a stent |
US8741378B1 (en) | 2001-06-27 | 2014-06-03 | Advanced Cardiovascular Systems, Inc. | Methods of coating an implantable device |
US7682669B1 (en) | 2001-07-30 | 2010-03-23 | Advanced Cardiovascular Systems, Inc. | Methods for covalently immobilizing anti-thrombogenic material into a coating on a medical device |
US7304122B2 (en) | 2001-08-30 | 2007-12-04 | Cornell Research Foundation, Inc. | Elastomeric functional biodegradable copolyester amides and copolyester urethanes |
US8303651B1 (en) | 2001-09-07 | 2012-11-06 | Advanced Cardiovascular Systems, Inc. | Polymeric coating for reducing the rate of release of a therapeutic substance from a stent |
US8173199B2 (en) | 2002-03-27 | 2012-05-08 | Advanced Cardiovascular Systems, Inc. | 40-O-(2-hydroxy)ethyl-rapamycin coated stent |
US8961588B2 (en) | 2002-03-27 | 2015-02-24 | Advanced Cardiovascular Systems, Inc. | Method of coating a stent with a release polymer for 40-O-(2-hydroxy)ethyl-rapamycin |
US8506617B1 (en) | 2002-06-21 | 2013-08-13 | Advanced Cardiovascular Systems, Inc. | Micronized peptide coated stent |
US7901703B2 (en) | 2002-06-21 | 2011-03-08 | Advanced Cardiovascular Systems, Inc. | Polycationic peptides for cardiovascular therapy |
US8067023B2 (en) | 2002-06-21 | 2011-11-29 | Advanced Cardiovascular Systems, Inc. | Implantable medical devices incorporating plasma polymerized film layers and charged amino acids |
US7875286B2 (en) | 2002-06-21 | 2011-01-25 | Advanced Cardiovascular Systems, Inc. | Polycationic peptide coatings and methods of coating implantable medical devices |
US7803406B2 (en) | 2002-06-21 | 2010-09-28 | Advanced Cardiovascular Systems, Inc. | Polycationic peptide coatings and methods of coating implantable medical devices |
US7794743B2 (en) | 2002-06-21 | 2010-09-14 | Advanced Cardiovascular Systems, Inc. | Polycationic peptide coatings and methods of making the same |
US9084671B2 (en) | 2002-06-21 | 2015-07-21 | Advanced Cardiovascular Systems, Inc. | Methods of forming a micronized peptide coated stent |
US7803394B2 (en) | 2002-06-21 | 2010-09-28 | Advanced Cardiovascular Systems, Inc. | Polycationic peptide hydrogel coatings for cardiovascular therapy |
US8647655B2 (en) | 2002-12-11 | 2014-02-11 | Abbott Cardiovascular Systems Inc. | Biocompatible polyacrylate compositions for medical applications |
US8871883B2 (en) | 2002-12-11 | 2014-10-28 | Abbott Cardiovascular Systems Inc. | Biocompatible coating for implantable medical devices |
US8871236B2 (en) | 2002-12-11 | 2014-10-28 | Abbott Cardiovascular Systems Inc. | Biocompatible polyacrylate compositions for medical applications |
US7776926B1 (en) | 2002-12-11 | 2010-08-17 | Advanced Cardiovascular Systems, Inc. | Biocompatible coating for implantable medical devices |
US8986726B2 (en) | 2002-12-11 | 2015-03-24 | Abbott Cardiovascular Systems Inc. | Biocompatible polyacrylate compositions for medical applications |
US7648725B2 (en) | 2002-12-12 | 2010-01-19 | Advanced Cardiovascular Systems, Inc. | Clamp mandrel fixture and a method of using the same to minimize coating defects |
US8435550B2 (en) | 2002-12-16 | 2013-05-07 | Abbot Cardiovascular Systems Inc. | Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device |
US8586069B2 (en) | 2002-12-16 | 2013-11-19 | Abbott Cardiovascular Systems Inc. | Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders |
US8673334B2 (en) | 2003-05-08 | 2014-03-18 | Abbott Cardiovascular Systems Inc. | Stent coatings comprising hydrophilic additives |
US9175162B2 (en) | 2003-05-08 | 2015-11-03 | Advanced Cardiovascular Systems, Inc. | Methods for forming stent coatings comprising hydrophilic additives |
US7785512B1 (en) | 2003-07-31 | 2010-08-31 | Advanced Cardiovascular Systems, Inc. | Method and system of controlled temperature mixing and molding of polymers with active agents for implantable medical devices |
US9114198B2 (en) | 2003-11-19 | 2015-08-25 | Advanced Cardiovascular Systems, Inc. | Biologically beneficial coatings for implantable devices containing fluorinated polymers and methods for fabricating the same |
US8192752B2 (en) | 2003-11-21 | 2012-06-05 | Advanced Cardiovascular Systems, Inc. | Coatings for implantable devices including biologically erodable polyesters and methods for fabricating the same |
US8052912B2 (en) | 2003-12-01 | 2011-11-08 | Advanced Cardiovascular Systems, Inc. | Temperature controlled crimping |
USRE45744E1 (en) | 2003-12-01 | 2015-10-13 | Abbott Cardiovascular Systems Inc. | Temperature controlled crimping |
US7786249B2 (en) | 2003-12-19 | 2010-08-31 | Advanced Cardiovascular Systems, Inc. | Biobeneficial polyamide/polyethylene glycol polymers for use with drug eluting stents |
US7772359B2 (en) | 2003-12-19 | 2010-08-10 | Advanced Cardiovascular Systems, Inc. | Biobeneficial polyamide/polyethylene glycol polymers for use with drug eluting stents |
US8685431B2 (en) | 2004-03-16 | 2014-04-01 | Advanced Cardiovascular Systems, Inc. | Biologically absorbable coatings for implantable devices based on copolymers having ester bonds and methods for fabricating the same |
US8778014B1 (en) | 2004-03-31 | 2014-07-15 | Advanced Cardiovascular Systems, Inc. | Coatings for preventing balloon damage to polymer coated stents |
US7820732B2 (en) | 2004-04-30 | 2010-10-26 | Advanced Cardiovascular Systems, Inc. | Methods for modulating thermal and mechanical properties of coatings on implantable devices |
US9101697B2 (en) | 2004-04-30 | 2015-08-11 | Abbott Cardiovascular Systems Inc. | Hyaluronic acid based copolymers |
US8293890B2 (en) | 2004-04-30 | 2012-10-23 | Advanced Cardiovascular Systems, Inc. | Hyaluronic acid based copolymers |
US9561309B2 (en) | 2004-05-27 | 2017-02-07 | Advanced Cardiovascular Systems, Inc. | Antifouling heparin coatings |
US9364498B2 (en) | 2004-06-18 | 2016-06-14 | Abbott Cardiovascular Systems Inc. | Heparin prodrugs and drug delivery stents formed therefrom |
US9375445B2 (en) | 2004-06-18 | 2016-06-28 | Abbott Cardiovascular Systems Inc. | Heparin prodrugs and drug delivery stents formed therefrom |
US8017140B2 (en) | 2004-06-29 | 2011-09-13 | Advanced Cardiovascular System, Inc. | Drug-delivery stent formulations for restenosis and vulnerable plaque |
US7758881B2 (en) | 2004-06-30 | 2010-07-20 | Advanced Cardiovascular Systems, Inc. | Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device |
US8758801B2 (en) | 2004-07-30 | 2014-06-24 | Abbott Cardiocascular Systems Inc. | Coatings for implantable devices comprising poly(hydroxy-alkanoates) and diacid linkages |
US8586075B2 (en) | 2004-07-30 | 2013-11-19 | Abbott Cardiovascular Systems Inc. | Coatings for implantable devices comprising poly(hydroxy-alkanoates) and diacid linkages |
US9580558B2 (en) | 2004-07-30 | 2017-02-28 | Abbott Cardiovascular Systems Inc. | Polymers containing siloxane monomers |
US8357391B2 (en) | 2004-07-30 | 2013-01-22 | Advanced Cardiovascular Systems, Inc. | Coatings for implantable devices comprising poly (hydroxy-alkanoates) and diacid linkages |
US7648727B2 (en) | 2004-08-26 | 2010-01-19 | Advanced Cardiovascular Systems, Inc. | Methods for manufacturing a coated stent-balloon assembly |
US7766884B2 (en) | 2004-08-31 | 2010-08-03 | Advanced Cardiovascular Systems, Inc. | Polymers of fluorinated monomers and hydrophilic monomers |
US8110211B2 (en) | 2004-09-22 | 2012-02-07 | Advanced Cardiovascular Systems, Inc. | Medicated coatings for implantable medical devices including polyacrylates |
US8603634B2 (en) | 2004-10-27 | 2013-12-10 | Abbott Cardiovascular Systems Inc. | End-capped poly(ester amide) copolymers |
US9067000B2 (en) | 2004-10-27 | 2015-06-30 | Abbott Cardiovascular Systems Inc. | End-capped poly(ester amide) copolymers |
US7749263B2 (en) | 2004-10-29 | 2010-07-06 | Abbott Cardiovascular Systems Inc. | Poly(ester amide) filler blends for modulation of coating properties |
US8609123B2 (en) | 2004-11-29 | 2013-12-17 | Advanced Cardiovascular Systems, Inc. | Derivatized poly(ester amide) as a biobeneficial coating |
US7892592B1 (en) | 2004-11-30 | 2011-02-22 | Advanced Cardiovascular Systems, Inc. | Coating abluminal surfaces of stents and other implantable medical devices |
US9339592B2 (en) | 2004-12-22 | 2016-05-17 | Abbott Cardiovascular Systems Inc. | Polymers of fluorinated monomers and hydrocarbon monomers |
US7699889B2 (en) | 2004-12-27 | 2010-04-20 | Advanced Cardiovascular Systems, Inc. | Poly(ester amide) block copolymers |
US8007775B2 (en) | 2004-12-30 | 2011-08-30 | Advanced Cardiovascular Systems, Inc. | Polymers containing poly(hydroxyalkanoates) and agents for use with medical articles and methods of fabricating the same |
US7795467B1 (en) | 2005-04-26 | 2010-09-14 | Advanced Cardiovascular Systems, Inc. | Bioabsorbable, biobeneficial polyurethanes for use in medical devices |
US8778375B2 (en) | 2005-04-29 | 2014-07-15 | Advanced Cardiovascular Systems, Inc. | Amorphous poly(D,L-lactide) coating |
US7823533B2 (en) | 2005-06-30 | 2010-11-02 | Advanced Cardiovascular Systems, Inc. | Stent fixture and method for reducing coating defects |
US8021676B2 (en) | 2005-07-08 | 2011-09-20 | Advanced Cardiovascular Systems, Inc. | Functionalized chemically inert polymers for coatings |
US7785647B2 (en) | 2005-07-25 | 2010-08-31 | Advanced Cardiovascular Systems, Inc. | Methods of providing antioxidants to a drug containing product |
US7735449B1 (en) | 2005-07-28 | 2010-06-15 | Advanced Cardiovascular Systems, Inc. | Stent fixture having rounded support structures and method for use thereof |
US8652504B2 (en) | 2005-09-22 | 2014-02-18 | Medivas, Llc | Solid polymer delivery compositions and methods for use thereof |
US9102830B2 (en) | 2005-09-22 | 2015-08-11 | Medivas, Llc | Bis-(α-amino)-diol-diester-containing poly (ester amide) and poly (ester urethane) compositions and methods of use |
US7976891B1 (en) | 2005-12-16 | 2011-07-12 | Advanced Cardiovascular Systems, Inc. | Abluminal stent coating apparatus and method of using focused acoustic energy |
US8067025B2 (en) | 2006-02-17 | 2011-11-29 | Advanced Cardiovascular Systems, Inc. | Nitric oxide generating medical devices |
US7713637B2 (en) | 2006-03-03 | 2010-05-11 | Advanced Cardiovascular Systems, Inc. | Coating containing PEGylated hyaluronic acid and a PEGylated non-hyaluronic acid polymer |
US8304012B2 (en) | 2006-05-04 | 2012-11-06 | Advanced Cardiovascular Systems, Inc. | Method for drying a stent |
US7985441B1 (en) | 2006-05-04 | 2011-07-26 | Yiwen Tang | Purification of polymers for coating applications |
US8069814B2 (en) | 2006-05-04 | 2011-12-06 | Advanced Cardiovascular Systems, Inc. | Stent support devices |
US7775178B2 (en) | 2006-05-26 | 2010-08-17 | Advanced Cardiovascular Systems, Inc. | Stent coating apparatus and method |
US9561351B2 (en) | 2006-05-31 | 2017-02-07 | Advanced Cardiovascular Systems, Inc. | Drug delivery spiral coil construct |
US8568764B2 (en) | 2006-05-31 | 2013-10-29 | Advanced Cardiovascular Systems, Inc. | Methods of forming coating layers for medical devices utilizing flash vaporization |
US8703167B2 (en) | 2006-06-05 | 2014-04-22 | Advanced Cardiovascular Systems, Inc. | Coatings for implantable medical devices for controlled release of a hydrophilic drug and a hydrophobic drug |
US8029816B2 (en) | 2006-06-09 | 2011-10-04 | Abbott Cardiovascular Systems Inc. | Medical device coated with a coating containing elastin pentapeptide VGVPG |
US8778376B2 (en) | 2006-06-09 | 2014-07-15 | Advanced Cardiovascular Systems, Inc. | Copolymer comprising elastin pentapeptide block and hydrophilic block, and medical device and method of treating |
US8062350B2 (en) | 2006-06-14 | 2011-11-22 | Abbott Cardiovascular Systems Inc. | RGD peptide attached to bioabsorbable stents |
US8114150B2 (en) | 2006-06-14 | 2012-02-14 | Advanced Cardiovascular Systems, Inc. | RGD peptide attached to bioabsorbable stents |
US8118863B2 (en) | 2006-06-14 | 2012-02-21 | Abbott Cardiovascular Systems Inc. | RGD peptide attached to bioabsorbable stents |
US9028859B2 (en) | 2006-07-07 | 2015-05-12 | Advanced Cardiovascular Systems, Inc. | Phase-separated block copolymer coatings for implantable medical devices |
US8703169B1 (en) | 2006-08-15 | 2014-04-22 | Abbott Cardiovascular Systems Inc. | Implantable device having a coating comprising carrageenan and a biostable polymer |
US8597673B2 (en) | 2006-12-13 | 2013-12-03 | Advanced Cardiovascular Systems, Inc. | Coating of fast absorption or dissolution |
US8147769B1 (en) | 2007-05-16 | 2012-04-03 | Abbott Cardiovascular Systems Inc. | Stent and delivery system with reduced chemical degradation |
US9056155B1 (en) | 2007-05-29 | 2015-06-16 | Abbott Cardiovascular Systems Inc. | Coatings having an elastic primer layer |
US8109904B1 (en) | 2007-06-25 | 2012-02-07 | Abbott Cardiovascular Systems Inc. | Drug delivery medical devices |
US10076591B2 (en) | 2010-03-31 | 2018-09-18 | Abbott Cardiovascular Systems Inc. | Absorbable coating for implantable device |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SU905228A1 (en) | Method for preparing thiourea | |
EP0130935B1 (en) | Biodegradable polypeptide and its use in the sustained release of medicaments | |
EP0179023B1 (en) | With micro-organisms degradable polypeptide, and its use for the progressive release of medicaments | |
SU872531A1 (en) | Method of producing polyurethans | |
EP0129396A2 (en) | Biocompatible poly-(ether-urethane-urea) and process for its preparation | |
Dey et al. | Hydrolytically degradable, dendritic polyglycerol sulfate based injectable hydrogels using strain promoted azide–alkyne cycloaddition reaction | |
Huynh et al. | Preparation and swelling properties of “click” hydrogel from polyaspartamide derivatives using tri-arm PEG and PEG-co-poly (amino urethane) azides as crosslinking agents | |
JPH01284529A (en) | Maleimide functional group-containing aromatic polyamideimide, its production and use thereof in production of crosslinked polymer | |
JP4628951B2 (en) | Compound having phosphorylcholine group, polymer thereof and method for producing the same | |
FR2501698A1 (en) | PROCESS FOR THE PREPARATION OF POLYAMIDE-TYPE COMPOUNDS USING ALKALINE MONO-METAL SALT OF DICARBOXYLIC ACID | |
Yamada et al. | Synthesis and properties of polyurethanes containing phosphatidylcholine analogues in the polymer backbone | |
JP2665522B2 (en) | New alpha-oxyacid polymer | |
US10793670B2 (en) | Synthesis of tyrosine derived polyarylates | |
EP0424224B1 (en) | Nadimide resin based expanded materials | |
EP0159293A1 (en) | Film-forming polymeric material for use in dressings, and its production | |
Shi et al. | Biocompatible in situ-forming glycopolypeptide hydrogels | |
CA1336848C (en) | Process for the preparation of thermostables copoly (imide-amide), comprising diorganosiloxane groups | |
Karal-Yilmaz et al. | Synthesis and characterization of poly (L-lactic acid-co-ethylene oxide-co-aspartic acid) and its interaction with cells | |
JP3026629B2 (en) | Method for producing poly-γ-glutamic acid grafted product | |
KR102220444B1 (en) | Novel polymer containing multi hydroxyl group, menufacturing method of the polymer, and complex comprising the polymer | |
SU504801A1 (en) | The method of producing polyureas | |
Yamada et al. | Synthesis and properties of polyurethanes containing phosphatidylcholine analogues in the side chains | |
RU2059609C1 (en) | 1-phenoxy-3,5-diaminobenzene as a monomer for synthesis of polyimides and polyamides and polyimides or polyamides on its basis as thermostable materials with improved processibility | |
US4043978A (en) | Polyimides | |
SU451339A1 (en) | Method of obtaining aromatic polyamidosulphamides |